GSI 250 (Viread 250 mg)
Generic Name: tenofovir
Pill with imprint GSI 250 is White, Capsule-shape and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc..
Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 250
Viread
- Generic Name:
- tenofovir
- Imprint:
- GSI 250
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- Inactive Ingredients:
- corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Viread (tenofovir)
- Viread Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 9 Reviews
- Generic Availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Viread
- Viread (Tenofovir Disoproxil Fumarate Oral Powder)
- Viread (Tenofovir Disoproxil Fumarate Tablets)
- Viread (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
